90127831 - KINNATE

Information

  • Trademark
  • 90127831
  • Serial Number
    90127831
  • Filing Date
    August 20, 2020
    4 years ago
  • Transaction Date
    March 18, 2024
    a year ago
  • Status Date
    March 18, 2024
    a year ago
  • Published for Opposition Date
    May 18, 2021
    3 years ago
  • Location Date
    February 15, 2022
    3 years ago
  • Status Code
    606
  • Current Location
    INTENT TO USE SECTION
    Employee Name
    SEGAL, MOLLY DANIELA
  • Law Office Assigned Location Code
    L50
  • Owners
Mark Drawing Code
4000
Mark Identification
KINNATE
Case File Statements
  • GS0051: therapeutic pharmaceuticals for the treatment of cancer; pharmaceutical products for the prevention and treatment of cancer; anti-cancer preparations; pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the endocrine system; pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in hematology, namely, for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of kidney diseases; antibacterial pharmaceuticals; pharmaceutical preparations for the prevention and treatment of allergies
  • GS0421: scientific research for medical purposes in the field of oncology; research and development of therapeutics for the treatment of cancer; research and development in the field of small molecule therapeutics; medical and scientific research in the field of cancer treatment and diagnosis; medical and scientific research in the field of pharmaceuticals; pharmaceutical products development
Case File Event Statements
  • 3/18/2024 - a year ago
    41 - ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Type: MAB6
  • 3/18/2024 - a year ago
    40 - ABANDONMENT - NO USE STATEMENT FILED Type: ABN6
  • 2/6/2024 - a year ago
    39 - WITHDRAWAL OF ATTORNEY GRANTED Type: WOAG
  • 2/6/2024 - a year ago
    38 - TEAS WITHDRAWAL OF ATTORNEY RECEIVED Type: WOAR
  • 6/1/2023 - a year ago
    37 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/30/2023 - a year ago
    36 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 5/30/2023 - a year ago
    35 - SOU EXTENSION 3 FILED Type: EXT3
  • 5/30/2023 - a year ago
    34 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 12/20/2022 - 2 years ago
    33 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 12/16/2022 - 2 years ago
    32 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 12/16/2022 - 2 years ago
    31 - SOU EXTENSION 2 FILED Type: EXT2
  • 12/16/2022 - 2 years ago
    30 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/20/2022 - 2 years ago
    29 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 7/18/2022 - 2 years ago
    28 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 7/18/2022 - 2 years ago
    27 - SOU EXTENSION 1 FILED Type: EXT1
  • 7/18/2022 - 2 years ago
    26 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 7/19/2022 - 2 years ago
    25 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 7/19/2022 - 2 years ago
    24 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 7/19/2022 - 2 years ago
    23 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 2/15/2022 - 3 years ago
    22 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 12/30/2021 - 3 years ago
    21 - TTAB RELEASE CASE TO TRADEMARKS Type: TMBN
  • 12/30/2021 - 3 years ago
    20 - OPPOSITION TERMINATED NO. 999999 Type: OP.T
  • 12/30/2021 - 3 years ago
    19 - OPPOSITION DISMISSED NO. 999999 Type: OP.D
  • 11/15/2021 - 3 years ago
    18 - OPPOSITION INSTITUTED NO. 999999 Type: OP.I
  • 9/28/2021 - 3 years ago
    17 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 9/28/2021 - 3 years ago
    16 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 9/28/2021 - 3 years ago
    15 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 6/10/2021 - 3 years ago
    14 - EXTENSION OF TIME TO OPPOSE RECEIVED Type: ETOF
  • 5/18/2021 - 3 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/18/2021 - 3 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 4/28/2021 - 3 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 4/15/2021 - 3 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 4/12/2021 - 3 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/12/2021 - 3 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/12/2021 - 3 years ago
    7 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 12/29/2020 - 4 years ago
    6 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 12/29/2020 - 4 years ago
    5 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 12/29/2020 - 4 years ago
    4 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 12/16/2020 - 4 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/24/2020 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 8/24/2020 - 4 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP